310 related articles for article (PubMed ID: 27663045)
1. [Predictors of medication non-adherence among a Moroccan sample of patients with schizophrenia: A cross sectional study].
El Ammouri A; Kisra H
Encephale; 2017 Dec; 43(6):522-527. PubMed ID: 27663045
[TBL] [Abstract][Full Text] [Related]
2. [Therapeutic benefit of a registered psychoeducation program on treatment adherence, objective and subjective quality of life: French pilot study for schizophrenia].
Sauvanaud F; Kebir O; Vlasie M; Doste V; Amado I; Krebs MO
Encephale; 2017 May; 43(3):235-240. PubMed ID: 27658989
[TBL] [Abstract][Full Text] [Related]
3. Treatment adherence and insight in schizophrenia.
Bitter I; Fehér L; Tényi T; Czobor P
Psychiatr Hung; 2015; 30(1):18-26. PubMed ID: 25867885
[TBL] [Abstract][Full Text] [Related]
4. [Rationale for the use of long-acting injectable risperidone: a survey of French psychiatrists].
Misdrahi D; Delgado A; Bouju S; Comet D; Chiariny JF
Encephale; 2013 May; 39 Suppl 1():S8-14. PubMed ID: 23541914
[TBL] [Abstract][Full Text] [Related]
5. Are we addressing the 'right stuff' to enhance adherence in schizophrenia? Understanding the role of insight and attitudes towards medication.
Beck EM; Cavelti M; Kvrgic S; Kleim B; Vauth R
Schizophr Res; 2011 Oct; 132(1):42-9. PubMed ID: 21820875
[TBL] [Abstract][Full Text] [Related]
6. The influence of therapeutic alliance and insight on medication adherence in schizophrenia.
Misdrahi D; Petit M; Blanc O; Bayle F; Llorca PM
Nord J Psychiatry; 2012 Feb; 66(1):49-54. PubMed ID: 21830849
[TBL] [Abstract][Full Text] [Related]
7. [Therapeutic alliance, a stake in schizophrenia].
Charpentier A; Goudemand M; Thomas P
Encephale; 2009 Feb; 35(1):80-9. PubMed ID: 19250998
[TBL] [Abstract][Full Text] [Related]
8. Factors associated with medication adherence among patients with schizophrenia in Mekelle, Northern Ethiopia.
Eticha T; Teklu A; Ali D; Solomon G; Alemayehu A
PLoS One; 2015; 10(3):e0120560. PubMed ID: 25816353
[TBL] [Abstract][Full Text] [Related]
9. Drug attitude and other predictors of medication adherence in schizophrenia: 12 months of electronic monitoring (MEMS(®)) in the Swedish COAST-study.
Brain C; Allerby K; Sameby B; Quinlan P; Joas E; Karilampi U; Lindström E; Eberhard J; Burns T; Waern M
Eur Neuropsychopharmacol; 2013 Dec; 23(12):1754-62. PubMed ID: 24091164
[TBL] [Abstract][Full Text] [Related]
10. Reliability and validity of the Medication Adherence Rating Scale in a cohort of patients with schizophrenia from Nigeria.
Owie GO; Olotu SO; James BO
Trends Psychiatry Psychother; 2018; 40(2):85-92. PubMed ID: 29768528
[TBL] [Abstract][Full Text] [Related]
11. [Relationships between insight and medication adherence in subjects with psychosis].
Droulout T; Liraud F; Verdoux H
Encephale; 2003; 29(5):430-7. PubMed ID: 14615692
[TBL] [Abstract][Full Text] [Related]
12. [Attributable risk of co-morbid substance use disorder in poor observance to pharmacological treatment and the occurrence of relapse in schizophrenia].
Ameller A; Gorwood P
Encephale; 2015 Apr; 41(2):174-83. PubMed ID: 25838239
[TBL] [Abstract][Full Text] [Related]
13. Factors associated with antipsychotic medication adherence in community-based patients with schizophrenia in Hong Kong: a cross sectional study.
Bressington D; Mui J; Gray R
Int J Ment Health Nurs; 2013 Feb; 22(1):35-46. PubMed ID: 22738372
[TBL] [Abstract][Full Text] [Related]
14. Predictors and clinical consequences of non-adherence with antipsychotic medication in the outpatient treatment of schizophrenia.
Novick D; Haro JM; Suarez D; Perez V; Dittmann RW; Haddad PM
Psychiatry Res; 2010 Apr; 176(2-3):109-13. PubMed ID: 20185182
[TBL] [Abstract][Full Text] [Related]
15. Exploring predictors of medication adherence among inpatients with schizophrenia in Singapore's mental health settings: A non-experimental study.
Tham XC; Xie H; Chng CML; Seah XY; Lopez V; Klainin-Yobas P
Arch Psychiatr Nurs; 2018 Aug; 32(4):536-548. PubMed ID: 30029745
[TBL] [Abstract][Full Text] [Related]
16. The influence of adherence to antipsychotics medication on the quality of life among patients with schizophrenia in Indonesia.
Endriyani L; Chien CH; Huang XY; Chieh-Yu L
Perspect Psychiatr Care; 2019 Apr; 55(2):147-152. PubMed ID: 29578605
[TBL] [Abstract][Full Text] [Related]
17. How do socio-demographic and clinical factors interact with adherence attitude profiles in schizophrenia? A cluster-analytical approach.
Beck EM; Cavelti M; Wirtz M; Kossowsky J; Vauth R
Psychiatry Res; 2011 May; 187(1-2):55-61. PubMed ID: 21074860
[TBL] [Abstract][Full Text] [Related]
18. Control beliefs, therapeutic relationship, and adherence in schizophrenia outpatients: a cross-sectional study.
Jaeger S; Weißhaupt S; Flammer E; Steinert T
Am J Health Behav; 2014 Nov; 38(6):914-23. PubMed ID: 25207516
[TBL] [Abstract][Full Text] [Related]
19. [Drug compliance and health locus of control in schizophrenia].
Combes C; Feral F
Encephale; 2011 May; 37 Suppl 1():S11-8. PubMed ID: 21600328
[TBL] [Abstract][Full Text] [Related]
20. Adherence to antipsychotic drug treatment in early-episode schizophrenia: a six-month naturalistic follow-up study.
Baloush-Kleinman V; Levine SZ; Roe D; Shnitt D; Weizman A; Poyurovsky M
Schizophr Res; 2011 Aug; 130(1-3):176-81. PubMed ID: 21636254
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
